<!DOCTYPE html><html><head><link href='https://fonts.googleapis.com/css?family=Spectral' rel='stylesheet'><style>body {    font-family: 'Spectral';font-size: 14px;}</style></head><body><b>Search Term: </b>"hematopoietic stem cells" AND CRISPR AND AAV AND ("sickle cell disease" OR "beta thalassemia")<br><b>Date run: </b>2020/01/05<br><br><h2>PubMed Articles</h2> <br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/30967552">Gene correction for SCID-X1 in long-term hematopoietic stem cells.</a></b><br><b>Journal:</b> Nat Commun<br><b>Two-year IF:</b> 11.80<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31492863">Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I.</a></b><br><b>Journal:</b> Nat Commun<br><b>Two-year IF:</b> 11.80<br><br><b><a href="https://ncbi.nlm.nih.gov/pubmed/31133730">Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations.</a></b><br><b>Journal:</b> Nat Mater<br><b>Two-year IF:</b> 31.03<br><br><b><a href="https://alexmakijokela.github.io/202001051944_hematopoietic.html#pubmed">More Results...</a></b><br><br><h2>Companies</h2> <br><br><b><a href="https://www.linkedin.com/company/crispr-therapeutics/about/">CRISPR Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/orchard-therapeutics/about/">Orchard Therapeutics</a></b><br><br><b><a href="https://www.linkedin.com/company/trucode-gene-repair-inc/about/">Trucode Gene Repair, Inc.</a></b><br><br><b><a href="https://alexmakijokela.github.io/202001051944_hematopoietic.html#companies">More Results...</a></b><br><br><h2>Patents</h2> <br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=11&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> September 17, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=12&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> September 10, 2019<br><br><b><a href="http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=7&p=1&f=G&l=50&d=PTXT&S1=(((%22hematopoietic+stem+cells%22+AND+CRISPR)+AND+AAV)+AND+(%22sickle+cell+disease%22+OR+%22beta+thalassemia%22))&OS="hematopoietic+stem+cells"+AND+CRISPR+AND+AAV+AND+("sickle+cell+disease"+OR+"beta+thalassemia")&RS=((("hematopoietic+stem+cells"+AND+CRISPR)+AND+AAV)+AND+("sickle+cell+disease"+OR+"beta+thalassemia"))">Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription</a></b><br><b>Patent date:</b> October 15, 2019<br><br><b><a href="https://alexmakijokela.github.io/202001051944_hematopoietic.html#patents">More Results...</a></b><br><br><br><b><a href="https://alexmakijokela.github.io/202001051944_hematopoietic.html">Link to Full Search Results</a></b><br></body></html>